Newsroom

Sorted by: Latest

-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

GXP-Storage Expands UK Capacity with Third Restricted-Access Facility at Raunds, Northamptonshire

RAUNDS, England--(BUSINESS WIRE)--GXP-Storage Ltd expands UK capacity with a new Raunds facility, adding 95,000+ cu ft of GxP-compliant storage from ambient to cryogenic....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 10.08.2026 FAPR.LN IE000WX2HZQ7  250,002.00 USD   6,545,152.35   26.180  ...
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-

GuidePoint Security Named to the Inc. 5000 List for the Eleventh Consecutive Year

RESTON, Va.--(BUSINESS WIRE)--GuidePoint Security is named to the Inc. 5000 list for the eleventh consecutive year....
-

Innovaccer Named to the Inc. 5000 List for the Fourth Time, Joining the Ranks of America's Fastest-Growing Private Companies

SAN FRANCISCO--(BUSINESS WIRE)--The honor places Innovaccer alongside past honorees like Microsoft, Meta, Chobani, Oracle, and Patagonia on the nation's most prestigious growth list....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 10.08.2026 FJUL.LN IE000YJBT6I5  100,002.00 USD   2,931,359.64   29.313  ...
-

Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe

BOLOGNA, Italy & MILAN, Italy--(BUSINESS WIRE)--Alfasigma S.p.A. (“Alfasigma”), a global pharmaceutical company, today announced that it has entered into a share purchase agreement with SEVER Life Sciences B.V. ("SEVER") for the sale of 100% of the shares of Nordic Group B.V. (“Nordic Pharma”) and its subsidiaries, a privately owned specialty pharmaceutical company with direct operations in Europe, Canada and Japan. The acquisition will add Nordic Pharma’s established rheumatoid arthritis busin...
-

Carelon Research and Manifold Partner to Expand Real-World Evidence Access for Life Sciences Researchers

BOSTON--(BUSINESS WIRE)--Carelon Research, a subsidiary of Elevance Health, and Manifold, an enterprise agent platform for life sciences, today announced a strategic partnership that gives life sciences researchers and data analysts secure, scalable access to high-quality, analysis-ready, real-world data in a protected environment, enabling faster, evidence-based decision-making. Through this collaboration, users can analyze Carelon Real World Data (RWD) alongside third-party datasets without m...